Table 5 Exploratory outcomes and safety measures

DREAM database

Weeks of work from baseline to current follow-up

X

X

Questionnaires

Symptoms of distress, anxiety, depression, and somatization measured by Four-Dimensional Symptom Questionnaire (4DSQ) [46]

X

X

X

X

Depressive symptoms measured by Beck Depression Inventory-II (BDI-II) [56]

X

X

X

Anxiety symptoms measured by Beck Anxiety Inventory (BAI)

X

X

X

Stress symptoms measured by Cohen et al.’s Perceived Stress Scale (PSS) [80]

X

X

X

Social and work-related function measured by WSAS [61]

X

X

X

Burnout symptoms measured by Karolinska Exhaustion Scale (KES) [62]

X

X

X

X

Health-related quality of life measured by EQ-5D-5L [81]

X

X

X

X

General quality of life scale measured by the Flanagan QOLS [65]

X

X

X

X

Self-efficacy concerning symptoms measured by IPQ subscale on personal control [66]

X

X

X

X

Return to work self-efficacy measured by RTW-SE [67]

X

X

X

X

General self-efficacy measured by General Self-Efficacy Scale (GSS) [68]

X

X

X

X

Client satisfaction with treatment measured by CSQ-8 [69]

X

Presenteeism measured by Stanford Presenteeism Scale (SPS) [82]

X

X

X

Use of therapy and therapy-like services outside IBBIS

X

X

X